Summary

Continuous Glucose Monitoring (CGM) System Market By Product Type (Sensors, Transmitters, Receivers), By Technology (Real-Time Continuous Glucose Monitoring (rtCGM), Flash Glucose Monitoring (FGM)), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Age Group (Pediatric Patients, Adult Population, Geriatric Population), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By End-user (Hospitals & Clinics, Diagnostic Centers, Homecare Settings, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 ? 2035
Continuous Glucose Monitoring (CGM) System market accounted for USD 7.5 Billion in 2024 and is expected to reach USD 28.2 Billion by 2035, growing at a CAGR of around 12.8% between 2025 and 2035. The continuous glucose monitoring (CGM) systems market essentially includes portable medical devices that measure levels of glucose in the bloodstream in real-time. An active and more precise alternative to common testing approaches, these devices depict continuous and dynamic changes in glucose levels. They are basically of higher value in the control of blood glucose levels to use early detection of fluctuations for those who happen to be diabetic. The market is legit booming due to the growing prevalence of diabetes, the increased health awareness, and the improvement of digital health technologies. The inclusion of applications in smartphones and AI-enhanced platforms is enriching the user experience and making improvements in clinical results. There will be some very good growth for the CGM market across developed and developing economies over the next few years, with a wider shift towards preventive healthcare and remote monitoring.
Rising Prevalence of Diabetes
One of the significant drivers spurring the CGM systems market is the increasing worldwide incidence of diabetes. The sedentary lifestyle and the unhealthy intake of food are pushing up the number of people at risk for or living with diabetes. This raises the need for better devices for diabetes monitoring and management. CGM systems give the user real-time information on their glucose level, which, in turn, prompts timely adjustments for treatment. With this increased knowledge regarding complications of poor glucose control, there is increased attitudinal change among individuals as well as healthcare providers in favor of CGM. Early adoption is also obvious among users who are prediabetic. This increase in the number of diabetic children and women with diabetes during pregnancy broadens the potential consumer base.
Technology Issues and Compliance of the Users
CGM products might also be facing, despite advancements in the technology, issues with sensor accuracy, skin irritancy, and malfunctioning devices. Trust and adherence may be impacted. Some users might use them inconsiderately, maybe feeling uncomfortable or seeing them as problematic. These will thus find their use proportionately random. Calibration and maintenance of the sensors put an extra burden on the user; this may, however, be difficult for elderly patients or those that are not technologically inclined. Other bright people may develop anxiety due to false alerting or data inaccuracy, which may also contribute to the clinicians' poor decision-making. Most of these problems require concerted technical support and a lot of training. Limited digital literacy and user fatigue decrease compliance further, short-circuiting long-term use.
Expansion in the Emerging Markets
Emerging economies have untapped potential for CGM manufacturers because of the growth of healthcare infrastructure and increasing awareness regarding the management of diabetes. Urbanization and lifestyle changes are some contributing factors to a diabetic population in these areas. Governments now are waking up to the idea of chronic disease care, thus supporting favorable regulatory environments. With the rise of disposable income, patients in these emerging markets are willing to spend on modern health technologies. A foothold can be established with local partnerships and inexpensive product versions. Educational campaigns also help improve acceptance. Thus, emerging markets happen to be the important eye to watch for future expansions.
Segment Analysis
In terms of technology, the CGM systems are classified as invasive or non-invasive. Right now, invasive systems that require the insertion of the sensors into the subcutaneous tissue are the predominant type of CGM system that is widely accepted due to their reliability and accuracy. Such devices provide fluxes of information on glucose trends and are often combined with insulin pumps for better diabetes care. The non-invasive way of providing CGM technology would have been measuring glucose without skin penetration and is still under development but promises well for the future. Innovations in biosensing materials and optical approaches for detecting glucose levels will continue to grow this sub-sector. With the evolution of and increase in non-invasive product lines, user preferences might be expected to undergo a drastic shift. Aggressive investment is being placed into R&D by market players, with a focus on performance and ease of use.
CGM systems are primarily being used in applications for diabetes control, although there is now a growing interest to cover both Type 1 and Type 2. This enables subsequent real-time decision-making towards therapy options for the patient and clinician. These machines have seen increased application even in gestational diabetes to prevent complications during the course of pregnancy. Some of the applications of CGM are utilized far beyond clinical use, such as wellness monitoring and fitness, particularly providing glucose insights useful to athletes and health-conscious people. Continuous data make it possible for diet optimization and insulin regulation and, therefore, decrease the risk of hyperglycemia and hypoglycemia. The CGM is applied in hospitals, home care, and diagnostic centers, where its usage differs according to different care intensities and monitoring requirements. And as personalized medicine grows, so too grows the potential use of CGM in varied applications.
Regional Analysis
The North American CGM market is the world's largest, thanks to technology being adopted very early on and having an established healthcare system. A high level of awareness exists regarding diabetes and its complications, making advanced monitoring instruments highly sought after. The existence of favorable regulations and a good reimbursement structure further ease penetration into this market. Continuous research and development by regional players bring innovations to market rapidly. Consumers generally have high awareness of mobile health trends and adoption rates of wearables. Some of the educational programs being run by health organizations also contribute toward growth. An added factor keeping demand strong is the prevalence of obesity-related diabetes in this region.
Competitive Landscape
The CGM system market is undergoing a high level of competition, as established medical device giants contend against innovative start-ups for market share. Important players are emphasizing product differentiation via improved sensor technology, longer wear times, and integrated interfacing with applications. Such strategic partnerships with health informatics firms and healthcare providers enhance their presence in these markets. Information on intellectual property, the design of sensors, and software platforms is quite significant in positioning competitively. These companies are also changing their sights to other demographics and end-use segments to expand their customer base. Mergers and acquisitions are a common way to ensure rapid expansion and absorption of technologies. The ability to provide a well-rounded digital diabetes care offering stands out as a huge advantage. Customer service and technical support remain a core differentiator in keeping long-term brand loyalty.
Report Coverage:
By Product Type
- Sensors
- Transmitters
- Receivers
By Application
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
By Technology
- Real-Time Continuous Glucose Monitoring (rtCGM)
- Flash Glucose Monitoring (FGM)
By Age Group
- Pediatric Patients
- Adult Population
- Geriatric Population
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online
By End User
- Hospitals & Clinics
- Diagnostic Centers
- Homecare Settings
- Others

ページTOPに戻る

Table of Contents

Table of Contents
1. Methodology & Report Coverage
1.1. Definition & Objective
1.2. Market Evaluation & forecast parameter
1.3. Research Methodology
1.4. Data Validation Sources
1.4.1. Secondary Research
1.4.2. Primary Research
2. Market Overview
3. Global Continuous Glucose Monitoring (CGM) System Market: Market Dynamics
3.1. Executive Summary
3.2. Market Driving Factors
3.2.1. The rising incidence of diabetes, particularly Type 1 and Type 2, is a major driver for Continuous Glucose Monitoring (CGM) systems.
3.2.2. Improvements in accuracy, reliability, and integration with other devices make Continuous Glucose Monitoring (CGM) more appealing to both patients and healthcare providers.
3.2.3. Continuous Glucose Monitoring (CGM) systems offer better glucose control, reduced HbA1c levels, and fewer hypoglycemic events compared to traditional glucose monitoring methods.
3.3. Key industry pitfalls & challenges
3.3.1. High costs limit accessibility, particularly in low-income and uninsured populations.
3.3.2. Issues with sensor adhesion, skin irritation, and the need for regular calibration can affect user compliance and satisfaction.
3.3.3. The disposable nature of CGM sensors, which often need to be replaced every few days to weeks, can be a drawback for users and contribute to ongoing costs and environmental concerns.
3.4. Market Opportunities
3.4.1. Advancements in non-invasive and minimally invasive sensor technologies offer opportunities to develop more comfortable and user-friendly CGM systems.
3.4.2. The growing trend of wearable health technology, such as smartwatches and fitness trackers, presents opportunities for integrating CGM systems with these devices.
3.4.3. Tailoring glucose monitoring and treatment based on individual needs and data insights can enhance patient outcomes.
3.5. Porter’s Five Forces Analysis
3.6. PESTLE Analysis
3.7. Regulatory landscape
3.8. Pipeline Analysis
3.9. ESG Scenario
3.10. Competitive landscape
3.10.1. Company Market Share
3.10.2. Market Positioning
3.10.3. Strategy framework
3.10.4. Recent Acquisitions & Mergers
4. Continuous Glucose Monitoring (CGM) System Market, Product Type Segment Analysis
4.1. Overview Dynamics
4.1.1. Market Revenue Share, By Product Type, 2025 & 2035
4.1.2. Key Market Trends, Growth Factors, & Opportunities
4.2. Sensors
4.2.1. Market Size and Forecast, By 2025-2035(USD Billion)
4.3. Transmitters
4.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
4.4. Receivers
4.4.1. Market Size and Forecast, By 2025-2035(USD Billion)
5. Continuous Glucose Monitoring (CGM) System Market, Application Segment Analysis
5.1. Overview
5.1.1. Market Revenue Share, By Application, 2025 & 2035
5.1.2. Key Market Trends, Growth Factors, & Opportunities
5.2. Type 1 Diabetes
5.2.1. Market Size and Forecast, By 2025-2035(USD Billion)
5.3. Type 2 Diabetes
5.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
5.4. Gestational Diabetes
5.4.1. Market Size and Forecast, By 2025-2035(USD Billion)
6. Continuous Glucose Monitoring (CGM) System Market, Technology Segment Analysis
6.1. Overview
6.1.1. Market Revenue Share, By Technology, 2025 & 2035
6.1.2. Key Market Trends, Growth Factors, & Opportunities
6.2. Real-Time Continuous Glucose Monitoring (RTCGM)
6.2.1. Market Size and Forecast, By 2025-2035(USD Billion)
6.3. Flash Glucose Monitoring (FGM)
6.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
7. Continuous Glucose Monitoring (CGM) System Market, Age Group Segment Analysis
7.1. Overview
7.1.1. Market Revenue Share, By Age Group, 2025 & 2035
7.1.2. Key Market Trends, Growth Factors, & Opportunities
7.2. Pediatric Patients
7.2.1. Market Size and Forecast, By 2025-2035(USD Billion)
7.3. Adult Population
7.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
7.4. Geriatric Population
7.4.1. Market Size and Forecast, By 2025-2035(USD Billion)
8. Continuous Glucose Monitoring (CGM) System Market, Distribution Channel Segment Analysis
8.1. Overview
8.1.1. Market Revenue Share, By Distribution Channel, 2025 & 2035
8.1.2. Key Market Trends, Growth Factors, & Opportunities
8.2. Hospital Pharmacies
8.2.1. Market Size and Forecast, By 2025-2035(USD Billion)
8.3. Retail Pharmacies
8.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
8.4. Online
8.4.1. Market Size and Forecast, By 2025-2035(USD Billion)
9. Continuous Glucose Monitoring (CGM) System Market, End User Segment Analysis
9.1. Overview
9.1.1. Market Revenue Share, By End User, 2025 & 2035
9.1.2. Key Market Trends, Growth Factors, & Opportunities
9.2. Hospitals & Clinics
9.2.1. Market Size and Forecast, By 2025-2035(USD Billion)
9.3. Diagnostic Centers
9.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
9.4. Homecare Settings
9.4.1. Market Size and Forecast, By 2025-2035(USD Billion)
9.5. Others
9.5.1. Market Size and Forecast, By 2025-2035(USD Billion)
10. Continuous Glucose Monitoring (CGM) System Market, Region Segment Analysis
10.1. Overview
10.1.1. Global Market Revenue Share, By Region, 2025 & 2035
10.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)
10.2. North America
10.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)
10.2.2. North America Market Revenue, By Product Type, 2025-2035
10.2.3. North America Market Revenue, By Application, 2025-2035
10.2.4. North America Market Revenue, By Technology, 2025-2035
10.2.5. North America Market Revenue, By Age Group, 2025-2035
10.2.6. North America Market Revenue, By Distribution Channel, 2025-2035
10.2.7. North America Market Revenue, By End User, 2025-2035
10.2.8. The U.S.
10.2.8.1. U.S. Market Revenue, By Product Type, 2025-2035
10.2.8.2. U.S. Market Revenue, By Application, 2025-2035
10.2.8.3. U.S. Market Revenue, By Technology, 2025-2035
10.2.8.4. U.S. Market Revenue, By Age Group, 2025-2035
10.2.8.5. U.S. Market Revenue, By Distribution Channel, 2025-2035
10.2.8.6. U.S. Market Revenue, By End User, 2025-2035
10.2.9. Canada
10.2.9.1. Canada Market Revenue, By Product Type, 2025-2035
10.2.9.2. Canada Market Revenue, By Application, 2025-2035
10.2.9.3. Canada Market Revenue, By Technology, 2025-2035
10.2.9.4. Canada Market Revenue, By Age Group, 2025-2035
10.2.9.5. Canada Market Revenue, By Distribution Channel, 2025-2035
10.2.9.6. Canada Market Revenue, By End User, 2025-2035
10.3. Europe
10.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)
10.3.2. Europe Market Revenue, By Product Type, 2025-2035
10.3.3. Europe Market Revenue, By Application, 2025-2035
10.3.4. Europe Market Revenue, By Technology, 2025-2035
10.3.5. Europe Market Revenue, By Age Group, 2025-2035
10.3.6. Europe Market Revenue, By Distribution Channel, 2025-2035
10.3.7. Europe Market Revenue, By End User, 2025-2035
10.3.8. Germany
10.3.8.1. Germany Market Revenue, By Product Type, 2025-2035
10.3.8.2. Germany Market Revenue, By Application, 2025-2035
10.3.8.3. Germany Market Revenue, By Technology, 2025-2035
10.3.8.4. Germany Market Revenue, By Age Group, 2025-2035
10.3.8.5. Germany Market Revenue, By Distribution Channel, 2025-2035
10.3.8.6. Germany Market Revenue, By End User, 2025-2035
10.3.9. France
10.3.9.1. France Market Revenue, By Product Type, 2025-2035
10.3.9.2. France Market Revenue, By Application, 2025-2035
10.3.9.3. France Market Revenue, By Technology, 2025-2035
10.3.9.4. France Market Revenue, By Age Group, 2025-2035
10.3.9.5. France Market Revenue, By Distribution Channel, 2025-2035
10.3.9.6. France Market Revenue, By End User, 2025-2035
10.3.10. U.K.
10.3.10.1. U.K. Market Revenue, By Product Type, 2025-2035
10.3.10.2. U.K. Market Revenue, By Application, 2025-2035
10.3.10.3. U.K Market Revenue, By Technology, 2025-2035
10.3.10.4. U.K Market Revenue, By Age Group, 2025-2035
10.3.10.5. U.K Market Revenue, By Distribution Channel, 2025-2035
10.3.10.6. U.K. Market Revenue, By End User, 2025-2035
10.3.11. Italy
10.3.11.1. Italy Market Revenue, By Product Type, 2025-2035
10.3.11.2. Italy Market Revenue, By Application, 2025-2035
10.3.11.3. Italy Market Revenue, By Technology, 2025-2035
10.3.11.4. Italy Market Revenue, By Age Group, 2025-2035
10.3.11.5. Italy Market Revenue, By Distribution Channel, 2025-2035
10.3.11.6. Italy Market Revenue, By End User, 2025-2035
10.3.12. Spain
10.3.12.1. Spain Market Revenue, By Product Type, 2025-2035
10.3.12.2. Spain Market Revenue, By Application, 2025-2035
10.3.12.3. Spain Market Revenue, By Technology, 2025-2035
10.3.12.4. Spain Market Revenue, By Age Group, 2025-2035
10.3.12.5. Spain Market Revenue, By Distribution Channel, 2025-2035
10.3.12.6. Spain Market Revenue, By End User, 2025-2035
10.3.13. Rest of Europe
10.3.13.1. Germany Market Revenue, By Product Type, 2025-2035
10.3.13.2. Germany Market Revenue, By Application, 2025-2035
10.3.13.3. Germany Market Revenue, By Technology, 2025-2035
10.3.13.4. Germany Market Revenue, By Age Group, 2025-2035
10.3.13.5. Germany Market Revenue, By Distribution Channel, 2025-2035
10.3.13.6. Germany Market Revenue, By End User, 2025-2035
10.4. Asia Pacific
10.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)
10.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035
10.4.3. Asia Pacific Market Revenue, By Application, 2025-2035
10.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035
10.4.5. Asia Pacific Market Revenue, By Age Group, 2025-2035
10.4.6. Asia Pacific Market Revenue, By Distribution Channel, 2025-2035
10.4.7. Asia Pacific Market Revenue, By End User, 2025-2035
10.4.8. China
10.4.8.1. China Market Revenue, By Product Type, 2025-2035
10.4.8.2. China Market Revenue, By Application, 2025-2035
10.4.8.3. China Market Revenue, By Technology, 2025-2035
10.4.8.4. China Market Revenue, By Age Group, 2025-2035
10.4.8.5. China Market Revenue, By Distribution Channel, 2025-2035
10.4.8.6. China Market Revenue, By End User, 2025-2035
10.4.9. Japan
10.4.9.1. Japan Market Revenue, By Product Type, 2025-2035
10.4.9.2. Japan Market Revenue, By Application, 2025-2035
10.4.9.3. Japan Market Revenue, By Technology, 2025-2035
10.4.9.4. Japan Market Revenue, By Age Group, 2025-2035
10.4.9.5. Japan Market Revenue, By Distribution Channel, 2025-2035
10.4.9.6. Japan Market Revenue, By End User, 2025-2035
10.4.10. India
10.4.10.1. India Market Revenue, By Product Type, 2025-2035
10.4.10.2. India Market Revenue, By Application, 2025-2035
10.4.10.3. India Market Revenue, By Technology, 2025-2035
10.4.10.4. India Market Revenue, By Age Group, 2025-2035
10.4.10.5. India Market Revenue, By Distribution Channel, 2025-2035
10.4.10.6. India Market Revenue, By End User, 2025-2035
10.4.11. Australia
10.4.11.1. Australia Market Revenue, By Product Type, 2025-2035
10.4.11.2. Australia Market Revenue, By Application, 2025-2035
10.4.11.3. Australia Market Revenue, By Technology, 2025-2035
10.4.11.4. Australia Market Revenue, By Age Group, 2025-2035
10.4.11.5. Australia Market Revenue, By Distribution Channel, 2025-2035
10.4.11.6. Australia Market Revenue, By End User, 2025-2035
10.4.12. South Korea
10.4.12.1. South Korea Market Revenue, By Product Type, 2025-2035
10.4.12.2. South Korea Market Revenue, By Application, 2025-2035
10.4.12.3. South Korea Market Revenue, By Technology, 2025-2035
10.4.12.4. South Korea Market Revenue, By Age Group, 2025-2035
10.4.12.5. South Korea Market Revenue, By Distribution Channel, 2025-2035
10.4.12.6. South Korea Market Revenue, By End User, 2025-2035
10.4.13. Singapore
10.4.13.1. Singapore Market Revenue, By Product Type, 2025-2035
10.4.13.2. Singapore Market Revenue, By Application, 2025-2035
10.4.13.3. Singapore Canada Market Revenue, By Technology, 2025-2035
10.4.13.4. Singapore Market Revenue, By Age Group, 2025-2035
10.4.13.5. Singapore Market Revenue, By Distribution Channel, 2025-2035
10.4.13.6. Singapore Market Revenue, By End User, 2025-2035
10.4.14. Rest of Asia Pacific
10.4.14.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035
10.4.14.2. Rest of Asia Pacific Market Revenue, By Application, 2025-2035
10.4.14.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035
10.4.14.4. Rest of Asia Pacific Market Revenue, By Age Group, 2025-2035
10.4.14.5. Rest of Asia Pacific Market Revenue, By Distribution Channel, 2025-2035
10.4.14.6. Rest of Asia Pacific Market Revenue, By End User, 2025-2035
10.5. Latin America
10.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)
10.5.2. Latin America Market Revenue, By Product Type, 2025-2035
10.5.3. Latin America Market Revenue, By Application, 2025-2035
10.5.4. Latin America Market Revenue, By Technology, 2025-2035
10.5.5. Latin America Market Revenue, By Age Group, 2025-2035
10.5.6. Latin America Market Revenue, By Distribution Channel, 2025-2035
10.5.7. Latin America Market Revenue, By End User, 2025-2035
10.5.7.1. Brazil Market Revenue, By Product Type, 2025-2035
10.5.7.2. Brazil Market Revenue, By Application, 2025-2035
10.5.7.3. Brazil Market Revenue, By Technology, 2025-2035
10.5.7.4. Brazil Market Revenue, By Age Group, 2025-2035
10.5.7.5. Brazil Market Revenue, By Distribution Channel, 2025-2035
10.5.7.6. Brazil Market Revenue, By End User, 2025-2035
10.5.8. Argentina
10.5.8.1. Argentina Market Revenue, By Product Type, 2025-2035
10.5.8.2. Argentina Market Revenue, By Application, 2025-2035
10.5.8.3. Argentina Market Revenue, By Technology, 2025-2035
10.5.8.4. Argentina Market Revenue, By Age Group, 2025-2035
10.5.8.5. Argentina Market Revenue, By Distribution Channel, 2025-2035
10.5.8.6. Argentina Market Revenue, By End User, 2025-2035
10.5.9. Mexico
10.5.9.1. Mexico Market Revenue, By Product Type, 2025-2035
10.5.9.2. Mexico Market Revenue, By Application, 2025-2035
10.5.9.3. Mexico Market Revenue, By Technology, 2025-2035
10.5.9.4. Mexico Market Revenue, By Age Group, 2025-2035
10.5.9.5. Mexico Market Revenue, By Distribution Channel, 2025-2035
10.5.9.6. Mexico Market Revenue, By End User, 2025-2035
10.5.10. Rest of Latin America
10.5.10.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035
10.5.10.2. Rest of Latin America Market Revenue, By Application, 2025-2035
10.5.10.3. Rest of Latin America Market Revenue, By Technology, 2025-2035
10.5.10.4. Rest of Latin America Market Revenue, By Age Group, 2025-2035
10.5.10.5. Rest of Latin America Market Revenue, By Distribution Channel, 2025-2035
10.5.10.6. Rest of Latin America Market Revenue, By End User, 2025-2035
10.6. MEA
10.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)
10.6.2. MEA Market Revenue, By Product Type, 2025-2035
10.6.3. MEA Market Revenue, By Application, 2025-2035
10.6.4. MEA Market Revenue, By Technology, 2025-2035
10.6.5. MEA Market Revenue, By Age Group, 2025-2035
10.6.6. MEA Market Revenue, By Distribution Channel, 2025-2035
10.6.7. MEA Market Revenue, By End User, 2025-2035
10.6.8. GCC Countries
10.6.8.1. GCC Countries Market Revenue, By Product Type, 2025-2035
10.6.8.2. GCC Countries Market Revenue, By Application, 2025-2035
10.6.8.3. GCC Countries Market Revenue, By Technology, 2025-2035
10.6.8.4. GCC Countries Market Revenue, By Age Group, 2025-2035
10.6.8.5. GCC Countries Market Revenue, By Distribution Channel, 2025-2035
10.6.8.6. GCC Countries Market Revenue, By End User, 2025-2035
10.6.9. South Africa
10.6.9.1. South Africa Countries Market Revenue, By Product Type, 2025-2035
10.6.9.2. South Africa Countries Market Revenue, By Application, 2025-2035
10.6.9.3. South Africa Countries Market Revenue, By Technology, 2025-2035
10.6.9.4. South Africa Countries Market Revenue, By Age Group, 2025-2035
10.6.9.5. South Africa Countries Market Revenue, By Distribution Channel, 2025-2035
10.6.9.6. South Africa Countries Market Revenue, By End User, 2025-2035
10.6.10. Rest of Middle-East Africa
10.6.10.1. Rest of Middle-East Africa Countries Market Revenue, By Product Type, 2025-2035
10.6.10.2. Rest of Middle-East Africa Countries Market Revenue, By Application, 2025-2035
10.6.10.3. Rest of Middle-East Africa Countries Market Revenue, By Technology, 2025-2035
10.6.10.4. Rest of Middle-East Africa Countries Market Revenue, By Age Group, 2025-2035
10.6.10.5. Rest of Middle-East Africa Countries Market Revenue, By Distribution Channel, 2025-2035
10.6.10.6. Rest of Middle-East Africa Countries Market Revenue, By End User, 2025-2035
11. Company Profile
11.1. Abbott Laboratories
11.1.1. Business Overview
11.1.2. Financial Performance
11.1.3. Product/Service Offerings
11.1.4. Strategies & recent developments
11.1.5. SWOT Analysis
11.2. Dexcom, Inc.
11.2.1. Business Overview
11.2.2. Financial Performance
11.2.3. Product/Service Offerings
11.2.4. Strategies & recent developments
11.2.5. SWOT Analysis
11.3. Medtronic plc
11.3.1. Business Overview
11.3.2. Financial Performance
11.3.3. Product/Service Offerings
11.3.4. Strategies & recent developments
11.3.5. SWOT Analysis
11.4. Johnson & Johnson
11.4.1. Business Overview
11.4.2. Financial Performance
11.4.3. Product/Service Offerings
11.4.4. Strategies & recent developments
11.4.5. SWOT Analysis
11.5. F. Hoffmann-La Roche Ltd.
11.5.1. Business Overview
11.5.2. Financial Performance
11.5.3. Product/Service Offerings
11.5.4. Strategies & recent developments
11.5.5. SWOT Analysis
11.6. Novo Nordisk
11.6.1. Business Overview
11.6.2. Financial Performance
11.6.3. Product/Service Offerings
11.6.4. Strategies & recent developments
11.6.5. SWOT Analysis
11.7. Senseonics Holdings, Inc.
11.7.1. Business Overview
11.7.2. Financial Performance
11.7.3. Product/Service Offerings
11.7.4. Strategies & recent developments
11.7.5. SWOT Analysis
11.8. A. Menarini Diagnostics
11.8.1. Business Overview
11.8.2. Financial Performance
11.8.3. Product/Service Offerings
11.8.4. Strategies & recent developments
11.8.5. SWOT Analysis
11.9. Bayer AG
11.9.1. Business Overview
11.9.2. Financial Performance
11.9.3. Product/Service Offerings
11.9.4. Strategies & recent developments
11.9.5. SWOT Analysis
11.10. GE Healthcare
11.10.1. Business Overview
11.10.2. Financial Performance
11.10.3. Product/Service Offerings
11.10.4. Strategies & recent developments
11.10.5. SWOT Analysis
11.11. Insulet Corporation
11.11.1. Business Overview
11.11.2. Financial Performance
11.11.3. Product/Service Offerings
11.11.4. Strategies & recent developments
11.11.5. SWOT Analysis
11.12. LifeScan
11.12.1. Business Overview
11.12.2. Financial Performance
11.12.3. Product/Service Offerings
11.12.4. Strategies & recent developments
11.12.5. SWOT Analysis
11.13. Ypsomed AG
11.13.1. Business Overview
11.13.2. Financial Performance
11.13.3. Product/Service Offerings
11.13.4. Strategies & recent developments
11.13.5. SWOT Analysis
11.14. GlySens Incorporated
11.14.1. Business Overview
11.14.2. Financial Performance
11.14.3. Product/Service Offerings
11.14.4. Strategies & recent developments
11.14.5. SWOT Analysis
11.15. Microchip Technology Inc.
11.15.1. Business Overview
11.15.2. Financial Performance
11.15.3. Product/Service Offerings
11.15.4. Strategies & recent developments
11.15.5. SWOT Analysis
11.16. STMicroelectronics
11.16.1. Business Overview
11.16.2. Financial Performance
11.16.3. Product/Service Offerings
11.16.4. Strategies & recent developments
11.16.5. SWOT Analysis
11.17. Medtrum Technologies, Inc.
11.17.1. Business Overview
11.17.2. Financial Performance
11.17.3. Product/Service Offerings
11.17.4. Strategies & recent developments
11.17.5. SWOT Analysis
11.18. Nemaura Medical, Inc.
11.18.1. Business Overview
11.18.2. Financial Performance
11.18.3. Product/Service Offerings
11.18.4. Strategies & recent developments
11.18.5. SWOT Analysis
11.19. Signos, Inc.
11.19.1. Business Overview
11.19.2. Financial Performance
11.19.3. Product/Service Offerings
11.19.4. Strategies & recent developments
11.19.5. SWOT Analysis
11.20. Qualcomm
11.20.1. Business Overview
11.20.2. Financial Performance
11.20.3. Product/Service Offerings
11.20.4. Strategies & recent developments
11.20.5. SWOT Analysis

ページTOPに戻る

List of Tables/Graphs

Tables
TABLE 1. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 2. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE FOR ACTIVATED CARBON, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE FOR CARBON DERIVATIVES, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE FOR METAL OXIDES, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE FOR CONDUCTIVE POLYMERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE FOR CONSUMER ELECTRONICS, 2025-2035 (USD BILLION)
TABLE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE FOR INDUSTRIAL, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 12. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
TABLE 13. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 14. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 15. U.S CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 16. U.S CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 17. CANADA CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 18. CANADA CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 19. EUROPE CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
TABLE 20. EUROPE CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 21. EUROPE CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, APPLICATION, 2025-2035 (USD BILLION)
TABLE 22. GERMANY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 23. GERMANY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 24. U.K CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 25. U.K CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 26. FRANCE CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 27. FRANCE CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 28. ITALY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 29. ITALY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 30. SPAIN CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 31. SPAIN CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 32. ROE CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 33. ROE CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 34. ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
TABLE 35. ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 36. ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 37. CHINA CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 38. CHINA CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 39. INDIA CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 40. INDIA CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 41. JAPAN CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 42. JAPAN CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 43. REST OF APAC CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 44. REST OF APAC CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 45. REST OF WORLD CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY TECHNOLOGY, 2025-2035 (USD BILLION)
TABLE 46. REST OF WORLD CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 47. CABOT(NORIT): FINANCIALS
TABLE 48. CABOT(NORIT): PRODUCTS & SERVICES
TABLE 49. CABOT(NORIT): RECENT DEVELOPMENTS
TABLE 50. KURARY CO. LTD: FINANCIALS
TABLE 51. KURARY CO. LTD: PRODUCTS & SERVICES
TABLE 52. KURARY CO. LTD: RECENT DEVELOPMENTS
TABLE 53. BAYER MATERIALSCIENCE AG: FINANCIALS
TABLE 54. BAYER MATERIALSCIENCE AG: PRODUCTS & SERVICES
TABLE 55. BAYER MATERIALSCIENCE AG: RECENT DEVELOPMENTS
TABLE 56. CALGON CARBON CORPORATION: FINANCIALS
TABLE 57. CALGON CARBON CORPORATION: PRODUCTS & SERVICES
TABLE 58. CALGON CARBON CORPORATION: RECENT DEVELOPMENTS
TABLE 59. CARBON NT&F: FINANCIALS
TABLE 60. CARBON NT&F: PRODUCTS & SERVICES
TABLE 61. CARBON NT&F: RECENT DEVELOPMENTS
TABLE 62. SHENZHEN NTP: FINANCIALS
TABLE 63. SHENZHEN NTP: PRODUCTS & SERVICES
TABLE 64. SHENZHEN NTP: RECENT DEVELOPMENTS
TABLE 65. CECA SA: FINANCIALS
TABLE 66. CECA SA: PRODUCTS & SERVICES
TABLE 67. CECA SA: RECENT DEVELOPMENTS
TABLE 68. CNANO TECHNOLOGY: FINANCIALS
TABLE 69. CNANO TECHNOLOGY: PRODUCTS & SERVICES
TABLE 70. CNANO TECHNOLOGY: RECENT DEVELOPMENTS
TABLE 71. DONAU CHEMIE GROUP: FINANCIALS
TABLE 72. DONAU CHEMIE GROUP: PRODUCTS & SERVICES
TABLE 73. DONAU CHEMIE GROUP: RECENT DEVELOPMENTS
TABLE 74. SHOWA DENKO: FINANCIALS
TABLE 75. SHOWA DENKO: PRODUCTS & SERVICES
TABLE 76. SHOWA DENKO: RECENT DEVELOPMENTS